ADM2 and breast carcinoma: Based on our results, we speculate that ADM2 can be secreted by tumor stromal cells and bind to G protein-coupled receptors of breast cancer tumor cells through paracrine methods, thereby promoting the proliferation and invasion of breast cancer cells.